0001062993-22-018207.txt : 20220817 0001062993-22-018207.hdr.sgml : 20220817 20220817155325 ACCESSION NUMBER: 0001062993-22-018207 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 EFFECTIVENESS DATE: 20220817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Proteome Therapeutics Inc. CENTRAL INDEX KEY: 0001942884 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456175 FILM NUMBER: 221173813 BUSINESS ADDRESS: STREET 1: SUITE 109, 650 ALBANY STREET CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 617-358-7823 MAIL ADDRESS: STREET 1: SUITE 109, 650 ALBANY STREET CITY: BOSTON STATE: MA ZIP: 02118 D 1 primary_doc.xml X0708 D LIVE 0001942884 Advanced Proteome Therapeutics Inc. SUITE 109, 650 ALBANY STREET BOSTON MA MASSACHUSETTS 02118 617-358-7823 DELAWARE Bullet Therapeutics Inc. None Corporation true Paul Woodward Suite 109, 650 Albany Street Boston MA MASSACHUSETTS 02118 Executive Officer Director William Dickie Suite 109, 650 Albany Street Boston MA MASSACHUSETTS 02118 Director Benjamin Krantz Suite 109, 650 Albany Street Boston MA MASSACHUSETTS 02118 Executive Officer Director Other Decline to Disclose 06b false 2022-08-01 false true true common shares @ USD$0.025 per share. false 0 94000 94000 0 false 6 0 0 0 false Advanced Proteome Therapeutics Inc. /s/ Paul Woodward Paul Woodward CFO 2022-08-17